Cutaneous effects of the most commonly used antidepressant medication, the selective serotonin reuptake inhibitors

被引:51
作者
Krasowska, Dorota
Szymanek, Magdalena
Schwartz, Robert A.
Myslinski, Wojciech
机构
[1] Med Univ Lublin, Dept Dermatol, PL-20080 Lublin, Poland
[2] Med Univ Lublin, Dept Internal Med, PL-20080 Lublin, Poland
[3] Univ Med & Dent New Jersey, Dept Dermatol, Newark, NJ USA
关键词
D O I
10.1016/j.jaad.2006.10.020
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Selective seritonin reuptake inhibitors (SSRIs) are widely used antidepressants that are often safer than alternatives, but may produce a variety of cutaneous reactions including spontaneous bruising, pruritus, urticaria, angioedema, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, erythema nodosum, alopecia, hypertrichosis, leukocytoclastic vasculitis, and an acneiform eruption. We review this category of medications and its side effects. Many cutaneous alterations seen in association with SSRIs can be serious, some even life threatening. Because there appears to be cross-reactions between SSRIs, even though they have different chemical structures, it is advisable to use another family of antidepressants if an SSRI is linked with a serious skin eruption.
引用
收藏
页码:848 / 853
页数:6
相关论文
共 65 条
[1]   HAIR LOSS ASSOCIATED WITH FLUOXETINE TREATMENT [J].
ANANTH, J ;
ELMISHAUGH, A .
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1991, 36 (08) :621-621
[2]  
ARANTH J, 1992, AM J PSYCHIAT, V149, P412
[3]   EXTRAPYRAMIDAL SYMPTOMS WITH SELECTIVE SEROTONIN REUPTAKE INHIBITORS [J].
ARYA, DK .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 165 :728-733
[4]  
Beauquier B, 1998, ENCEPHALE, V24, P62
[5]   Exacerbation of migraine attacks during treatment with the selective serotonin reuptake inhibitor sertraline -: A case report [J].
Bickel, A ;
Kornhuber, J ;
Maihöfner, C ;
Ropohl, A .
PHARMACOPSYCHIATRY, 2005, 38 (06) :327-328
[6]   Paroxetine in a case of psychogenic pruritus and neurotic excoriations [J].
Biondi, M ;
Arcangeli, T ;
Petrucci, RM .
PSYCHOTHERAPY AND PSYCHOSOMATICS, 2000, 69 (03) :165-166
[7]  
BLACKSTERN J, 1993, ANN PHARMACOTHER, V27, P273
[8]  
BODOKH I, 1992, THERAPIE, V47, P441
[9]   PAROXETINE AND EXTRAPYRAMIDAL REACTIONS [J].
CHOO, V .
LANCET, 1993, 341 (8845) :624-624
[10]   THE SAFETY OF FLUOXETINE - AN UPDATE [J].
COOPER, GL .
BRITISH JOURNAL OF PSYCHIATRY, 1988, 153 :77-86